A1C alone misses early metabolic dysfunction. Tracking fasting insulin, HOMA-IR, the triglyceride-to-HDL ratio, and continuous glucose data reveals insulin resistance years before A1C rises. Catching it early lets nutrition, sleep, and strength training reverse course while it is still easy.
TL;DR: A1C is a lagging indicator. It tells us your average blood sugar over the past 90 days, but it misses the silent work your body does to keep those numbers stable. At Fishtown Medicine, we track fasting insulin and HOMA-IR to identify metabolic dysfunction years before A1C ever changes.
Table of Contents
- Why is A1C a lagging indicator?
- What do we test instead of just A1C?
- Why does early detection of metabolic dysfunction matter?
- Guidelines from the Clinic
- Actionable Steps for Metabolic Reset
- Common Questions
- Deep Questions
Why is A1C a lagging indicator?
A1C is a lagging indicator because it averages blood sugar across roughly 90 days, after the body has already worked hard to keep glucose in range. Many patients are told they are fine because their A1C is below 5.7%, but that single number does not show:
- Insulin Compensation: How much insulin your pancreas pumps to keep glucose normal.
- Post-Meal Spikes: The glucose peaks that happen after eating.
- Glycemic Variability: How chaotic or stable your blood sugar is day to day.
- Silent Inflammation: Mitochondrial overload that precedes any rise in glucose.
If we only look at A1C, we are waiting for the engine to fail before checking the oil.
What do we test instead of just A1C?
We use a high-resolution metabolic audit to find the root causes of fatigue, central weight gain, and brain fog.
- Fasting Insulin: Often elevated a decade before blood sugar rises.
- HOMA-IR: A calculated score that measures how resistant your cells are to insulin.
- Triglyceride-to-HDL Ratio: A proven marker of metabolic health and cardiovascular risk.
- Continuous Glucose Monitors (CGM): We use preventive CGMs to track real-time response to food and stress.
- ApoB: To make sure your cardiovascular risk is addressed alongside metabolism.
- Liver Markers (ALT, GGT, fatty liver index): Early signals of fat accumulation in the liver.
- hs-CRP: A marker of systemic inflammation that often shadows insulin resistance.
Why does early detection of metabolic dysfunction matter?
Early detection matters because metabolic dysfunction is the base layer that accelerates the Four Horsemen of chronic disease.
- Cardiovascular Disease: High insulin damages the lining of arteries and drives plaque growth.
- Cancer Risk: Insulin is a growth-promoting hormone that can fuel malignant cells.
- Neurodegeneration: Brain insulin resistance is a major contributor to Alzheimer's and cognitive decline.
- Systemic Inflammation: Drives joint pain, PCOS, and low energy.
Catching it early lets simple changes (sleep, nutrition, strength training) reverse the trajectory before it becomes a diagnosis.
Guidelines from the Clinic
Actionable Steps for Metabolic Reset
Move beyond the average.
- Request a Fasting Insulin: The single most important test missing from a standard physical.
- Audit Your "Healthy" Carbs: Use a CGM or track energy after meals. If you crash after oatmeal or fruit, your insulin is likely overcompensating.
- Strengthen Your Glucose Sinks: Resistance training builds muscle, which acts as a glucose sink and lowers the demand on insulin.
- Walk After Meals: A 10-minute walk after lunch and dinner can lower post-meal glucose by 20 to 40 points in many people.
- Sleep First: One night under 6 hours measurably worsens insulin sensitivity. Sleep is the most underrated metabolic intervention.
Scientific References
- Reaven GM. Insulin Resistance: The Link Between Obesity and Cardiovascular Disease. Med Clin North Am. 2011;95(5):875-892.
- Crofts CAP, et al. Hyperinsulinemia: A Unifying Theory of Chronic Disease? Diabesity. 2015;1(4):34-43.
- Tabák AG, et al. Trajectories of Glycaemia, Insulin Sensitivity, and Insulin Secretion Before Diagnosis of Type 2 Diabetes. Lancet. 2009;373(9682):2215-2221.
- Kolb H, et al. Insulin Translates Unfavourable Lifestyle Into Obesity. BMC Med. 2018;16(1):232.
- Rinella ME, et al. AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease. Hepatology. 2023;77(5):1797-1835.
Dr. Ash is a board-certified internal medicine physician specializing in preventive medicine and healthspan optimization at Fishtown Medicine in Philadelphia.
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.




